{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["10"],"submitter":["Tseng HY"],"pubmed_abstract":["<h4>Background and aims</h4>Hepatorenal syndrome (HRS) is a disastrous renal complication of advanced liver disease with a poor prognosis. Restoring normal liver function through liver transplantation (LT) is a standardized treatment with favorable short-term survival. However, the long-term renal outcomes in patients with HRS receiving living donor LT (LDLT) are controversial. This study aimed to investigate the prognostic impact of LDLT in patients with HRS.<h4>Methods</h4>We reviewed adult patients who underwent LDLT between July 2008 and September 2017. Recipients were classified into 1) HRS type 1 (HRS1, <i>N</i> = 11), 2) HRS type 2 (HRS2, <i>N</i> = 19), 3) non-HRS recipients with pre-existing chronic kidney disease (CKD, <i>N</i> = 43), and 4) matched normal renal function (<i>N</i"],"journal":["Frontiers in surgery"],"pagination":["1116728"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10106629"],"repository":["biostudies-literature"],"pubmed_title":["Long-term renal outcomes comparison between patients with chronic kidney disease and hepatorenal syndrome after living donor liver transplantation."],"pmcid":["PMC10106629"],"pubmed_authors":["Chen CL","Yong CC","Tseng HY","Lin YH","Lin CC","Lin LM","Chan YC","Wang CC"],"additional_accession":[]},"is_claimable":false,"name":"Long-term renal outcomes comparison between patients with chronic kidney disease and hepatorenal syndrome after living donor liver transplantation.","description":"<h4>Background and aims</h4>Hepatorenal syndrome (HRS) is a disastrous renal complication of advanced liver disease with a poor prognosis. Restoring normal liver function through liver transplantation (LT) is a standardized treatment with favorable short-term survival. However, the long-term renal outcomes in patients with HRS receiving living donor LT (LDLT) are controversial. This study aimed to investigate the prognostic impact of LDLT in patients with HRS.<h4>Methods</h4>We reviewed adult patients who underwent LDLT between July 2008 and September 2017. Recipients were classified into 1) HRS type 1 (HRS1, <i>N</i> = 11), 2) HRS type 2 (HRS2, <i>N</i> = 19), 3) non-HRS recipients with pre-existing chronic kidney disease (CKD, <i>N</i> = 43), and 4) matched normal renal function (<i>N</i","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023","modification":"2025-04-18T14:52:47.271Z","creation":"2025-04-07T01:12:08.214Z"},"accession":"S-EPMC10106629","cross_references":{"pubmed":["37077866"],"doi":["10.3389/fsurg.2023.1116728"]}}